KEYNOTE PRESENTATIONS:
David Cho, Ph.D., M.P.H., Senior Scientist for Emerging
and PandemicThreat Preparedness, Office of the Director,
Center for Biologics Evaluation and Research (CBER), FDA
Norman Baylor, Ph.D., Director, Office of Vaccines Research
and Review (OVRR), Center forBiologics Evaluation and
Research (CBER), Food and Drug Administration, FDA
Jay Berzofsky, M.D., Ph.D., Chief, Vaccine Branch, Center
for Cancer Research, National Cancer Institute (NCI),
National Institutes of Health
George Siber, Ph.D., Director, Selecta Biosciences, and
Executive Chairman, Genocea Biosciences
|
EVENT HIGHLIGHTS:
- 4 Conferences, ONE Location!
- Over 60 Presentations
- Panel Discussions
- Exhibit & Poster Viewing
SHORT COURSES:
Monday, August 16
SC1 Vaccines Business Opportunities:
Collaborations, Mergers And Acquisitions
SC2 Single-Use Systems (Disposables) For
Vaccine Manufacture
|